A Phase 1a/1b Study of ACTM-838 in Patients With Advanced Solid Tumors
Actym Therapeutics, Inc.
Actym Therapeutics, Inc.
Telix Pharmaceuticals (Innovations) Pty Limited
Kinnate Biopharma
Elevation Oncology
Rain Oncology Inc
Hoffmann-La Roche
BIND Therapeutics